New Mumbai-Based Team and Strategic VAD Partnership will Initially Target Large Enterprise, Financial Institution, and Call Center Digital Identity Needs MADRID…
OSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for Lusvertikimab Development built on strong IL-7R biological…